Short Interest in Sensus Healthcare, Inc. (NASDAQ:SRTS) Declines By 18.1%

Sensus Healthcare, Inc. (NASDAQ:SRTS) was the target of a significant drop in short interest in November. As of November 30th, there was short interest totalling 486,100 shares, a drop of 18.1% from the November 15th total of 593,700 shares. Based on an average trading volume of 161,300 shares, the days-to-cover ratio is currently 3.0 days. Approximately 3.7% of the company’s stock are sold short.

Analysts Set New Price Targets

Several research firms have recently issued reports on SRTS. HC Wainwright upped their price objective on shares of Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a report on Monday, November 18th. Maxim Group raised their target price on shares of Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a report on Friday, November 15th.

Institutional Trading of Sensus Healthcare

A number of hedge funds have recently added to or reduced their stakes in SRTS. Truvestments Capital LLC acquired a new stake in Sensus Healthcare in the third quarter valued at approximately $32,000. Chapin Davis Inc. purchased a new position in shares of Sensus Healthcare during the 2nd quarter valued at approximately $53,000. XTX Topco Ltd acquired a new stake in Sensus Healthcare in the 2nd quarter valued at $95,000. Cubist Systematic Strategies LLC acquired a new position in Sensus Healthcare during the second quarter worth $156,000. Finally, Acadian Asset Management LLC lifted its holdings in Sensus Healthcare by 578.6% during the second quarter. Acadian Asset Management LLC now owns 45,124 shares of the company’s stock valued at $239,000 after purchasing an additional 38,474 shares in the last quarter. 25.30% of the stock is owned by hedge funds and other institutional investors.

Sensus Healthcare Price Performance

SRTS stock traded down $0.33 during trading on Friday, hitting $8.16. 220,473 shares of the company traded hands, compared to its average volume of 270,814. Sensus Healthcare has a 1 year low of $2.14 and a 1 year high of $9.33. The stock’s 50-day simple moving average is $7.46 and its 200 day simple moving average is $6.45. The company has a market cap of $133.74 million, a PE ratio of 14.32 and a beta of 1.16.

About Sensus Healthcare

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.